Literature DB >> 6155202

External carotid artery infusion with single-and multiple-drug regimens in the rat.

P F Schouwenburg, L M Van Putten, G B Snow.   

Abstract

An animal model was constructed using retrograde cannulation of a branch of the external carotid artery of rats in order to study the intraarterial (IA) and systemic effects of bleomycine, methotrexate, and 5-fluorouracil on a squamous cell carcinoma implanted in both ears. Continuous seven-day IA infusion of bleomycine and 5-fluorouracil proved to be superior to the systemic way by about a factor of 3. Unfortunately, the tumor did not respond to methotrexate and therefore, for this drug, no conclusion could be made as to the relative benefits of IA administration. Comparing simultaneous, sequential, and intermittent multiple-drug regimens, the last one showed an antitumor effect which was superior to either of the other schedules. It is concluded that IA administration of effective cytotoxic drugs is a superior treatment modality and that in this model IA intermittent multiple-drug therapy is the most successful schedule yet studied.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155202     DOI: 10.1002/1097-0142(19800501)45:9<2258::aid-cncr2820450907>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastases.

Authors:  E A Neuwelt; S A Dahlborg
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

2.  Pharmacokinetics of intra-arterial tumour therapy. An experimental study.

Authors:  J von Scheel; G Golde
Journal:  Arch Otorhinolaryngol       Date:  1984

3.  A new method for repeated drug infusion into the femoral artery of mice.

Authors:  Kersten Berndt; Johannes Vogel; Christopher Buehler; Peter Vogt; Walter Born; Bruno Fuchs
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-11       Impact factor: 1.232

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.